Interventions for the Wellbeing of Students At the University of Helsinki
Launched by UNIVERSITY OF HELSINKI · Aug 2, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Groups 4 Health (G4H), which aims to improve the well-being of students at the University of Helsinki. The focus is on helping students feel less lonely and more connected to others. Previous research in Australia has shown that G4H can effectively reduce feelings of loneliness and anxiety, and now the researchers want to see if it works just as well in Finland. They will compare G4H with other well-being programs offered at the university and see how these programs help students compared to those who do not participate in any well-being activities.
To be eligible for this trial, you need to be an adult (18 years or older) and a student at the University of Helsinki who can read or speak Finnish, Swedish, or English. Participants can expect to take part in various activities and fill out questionnaires before and after the program to help the researchers understand how effective the interventions are. This study will also look at the costs involved in the G4H program and explore any challenges related to making the program inclusive for all students. If you're interested in improving your well-being and connecting with others, this could be a great opportunity!
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Adult (age 18 and above)
- • Student in the University of Helsinki, Finland
- • Able to speak/read Finnish, Swedish, or English
- Exclusion criteria:
- • - None
About University Of Helsinki
The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, Uusimaa, Finland
Patients applied
Trial Officials
Jari M Lahti, PhD
Principal Investigator
University of Helsinki
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported